A next-generation Biotechnology company creating off-the-shelf cellular medicines for Cancer, Infectious Diseases, and Degenerative Diseases.
The Next Evolution In Cellular Medicine
Our goal is to turn living cells into medicines. At Celularity we aim to advance human health, quality of life, and longevity through the power of allogeneic placental-derived cells.
Active & Completed
Allogeneic Placenta Derived Cells
Celularity’s innovative approach to cell therapy harnesses the unique therapeutic potential locked within the cells of the postpartum placenta. We have multiple cell therapy candidates in pre-clinical and clinical development as well as placental-derived products for surgical use.
For Two Decades, the Vanguard of Cellular Medicine
From Our Founders
We were the company that discovered the value hidden inside these discarded placentas. I am proud of that. Nobody was really looking at it. I asked myself early on, “Why is it that every other resource is being looked at, but the placenta is being ignored?”
“Celularity is built on 20 years of research legacy by Dr. Hariri and his team. Bob’s mission has been to harness the power of the living cell to augment our biology, immunity and longevity. He is the Chairman and CEO, and I’ll support his efforts as Co-Founder and Executive Chairman.”
Experienced Cellular Medicine
Leaders & Innovators
Backed by 100+ years of combined experience, our seasoned team of biopharmaceutical executives, scientists and clinicians have been integral to the success of numerous programs across discovery research, clinical development and commercialization in cancer immunotherapies and cell therapeutics.